Company: INKT
Filing Date: 2025-03-18
Form Type: 10-K
Source: 0000950170-25-041379
Chunk: 138

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-03-18
Form: 10-K
Item: Item 1B
Chunk 138
---
040

    $
    3,367,229

    Prepaid expenses

    246,600

    53,111

    Other current assets

    164,244

    177,964

    Total current assets

    4,987,884

    3,598,304

    Equipment, net of accumulated depreciation of $524,639 and $495,638 as of    December 31, 2024 and 2023, respectively

    732,929

    953,977

    Total assets
     
    $
    5,720,813

    $
    4,552,281

    LIABILITIES AND STOCKHOLDERS’ DEFICIT

    Accounts payable

    2,728,212

    3,911,973

    Accrued liabilities

    1,873,561

    5,037,361

    Other current liabilities

    2,357,903

    2,453,251

    Total current liabilities

    6,959,676

    11,402,585

    Related party note

    4,924,612

    —

    Other long-term liabilities

    —

    48,072

    Due to related parties

    13,422,407

    11,157,073

    Commitments and contingencies

    Stockholders’ deficit

    Common stock, par value $0.00001 per share, 150,000,000 shares   authorized, 3,963,045 and 3,459,910 shares issued and outstanding as of    December 31, 2024 and 2023, respectively

    40

    35

    Additional paid-in capital

    125,227,389

    115,772,396

    Accumulated other comprehensive loss

    (631,576
    )

    (430,947
    )

    Accumulated deficit

    (144,181,735
    )

    (133,396,933
    )

    Total stockholders’ deficit

    (19,585,882
    )

    (18,055,449
    )

    Total liabilities and stockholders’ deficit
     
    $
    5,720,813

    $
    4,552,281

See accompanying notes to consolidated financial